Traditional diagnostic methods, such as bacterial culture and PCR-based testing, can take 24–72 hours, delaying critical treatment decisions. In contrast, PathCrisp enables direct detection from clinical samples without the need for expensive equipment or prolonged culture processes, ensuring early recognition and targeted therapy.”
